A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients.

Philip Roland SelbySepehr ShakibSandra L PeakeMorgyn S WarnerDavid YeungUwe HahnJason A Roberts

Published in: Clinical pharmacokinetics (2021)

Further studies of the pharmacokinetics, pharmacodynamics and toxicodynamics of GCV/VGCV in alloHCT patients are required to identify a more robust therapeutic range and to subsequently quantify the potential value of therapeutic drug monitoring of GCV/VGCV in the alloHCT population.

Keyphrases

end stage renal disease
stem cells
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
risk assessment
bone marrow
low dose
high dose
patient reported outcomes
climate change
cell therapy
human health